Author:
Cyran Clemens C.,Sennino Barbara,Chaopathomkul Bundit,Fu Yanjun,Rogut Victor S.,Shames David M.,Wendland Michael F.,McDonald Donald M.,Brasch Robert C.
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine
Reference37 articles.
1. Mellin GW, Katzenstein M (1962) The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies. N Engl J Med 267:1184–1192
2. D’Amato RJ, Loughnan MS, Flynn E, Folkman J (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91(9):4082–4085
3. Bolke E, Gripp S, Peiper M, Budach W, Schwarz A, Orth K, Reinecke P, van de Nes JA (2006) Multifocal epithelioid hemangioendothelioma: case report of a clinical chamaeleon. Eur J Med Res 11(11):462–466
4. Klausner JD, Freedman VH, Kaplan G (1996) Thalidomide as an anti-TNF-alpha inhibitor: implications for clinical use. Clin Immunol Immunopathol 81(3):219–223
5. Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G (1993) Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med 177(6):1675–1680